Envision Pharma - M&A Summary, Ownership, and Business Overview

Information TechnologyCompany

Envision Pharma M&A Summary

Envision Pharma has acquired 5 companies of its own, including 3 in the last 5 years. A total of 1 acquisition came from private equity firms.

Envision Pharma has acquired in 3 different US states, and 3 countries. The Company’s most targeted sectors include business services (40%) and information technology (20%).

Envision Pharma Ownership

Who owns Envision Pharma?

Envision Pharma is owned by Ardian, GHO Capital Partners, HarbourVest Partners, Mubadala Capital and Northwestern Mutual Capital. It was acquired on July 6, 2016.

Is Envision Pharma PE-backed?

Yes. Envision Pharma is owned by private equity investors Ardian, GHO Capital Partners, HarbourVest Partners, Mubadala Capital and Northwestern Mutual Capital.

Was Envision Pharma formerly PE-backed?

Yes. Envision Pharma was formerly owned by 1 private investor.

Envision Pharma Business Overview

Where is Envision Pharma headquartered?

Envision Pharma is headquartered in Horsham, United Kingdom.

What sector is Envision Pharma in?

Envision Pharma is an information technology company.

When was Envision Pharma founded?

Envision Pharma was founded in 2001.

M&A Summary

  • M&A Total Activity5
    • M&A Buy Activity5
  • Total Sectors Invested 4
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 1

Envision Pharma

Envision Pharma, Inc.

5 North Street,
Horsham, RH12 1XQ
United Kingdom,
+44 (0) 1403 322 000
www.envisionpharmagroup.com

Envision Pharma is a global technology and scientific communication company serving the pharmaceutical, biotechnology, and medical device companies. Envision has grown steadily under consistent leadership across its three core business areas that include scientific solutions – strategic publication planning and related data dissemination services, technology Solutions – design, development, implementation, and support of innovative and strategic management software for life sciences clients including publication planning and management (DatavisionTM), clearance approval (dvClear), and activity request management (Visiontracker) and professional consulting solutions policy, process, compliance and guideline consultancy to life-science companies. Envision Pharma was founded in 2001 and is based in Horsham, United Kingdom.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.6/yr) # 2 2 1 - - - 5
Sell (0.0/yr) # - - - - - - 0
  5

Most Recent M&A

Company Date Value Type
doDOC Corp. 2021-03-22 - Add-on Acquisition
Boston, Massachusetts · www.dodoc.com
Two Labs LLC 2020-11-12 - Add-on Acquisition
Powell, Ohio · www.twolabs.com
90TEN Group Ltd. 2020-04-08 - Add-on Acquisition
London, United Kingdom · www.90ten.co.uk
Alligent Biopharm Consulting LLC 2015-09-09 - Add-on Acquisition
Stirling, New Jersey · www.alligentgroup.com
ProScribe Pty Ltd. 2014-01-17 - Add-on Acquisition
Noosaville, Australia
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Business Services 2 (40%) - - -
Information Technology 1 (20%) - - -
Internet Software and Services 1 (20%) - - -
Life Science 1 (20%) - - -
Total 5 - - -

By Geo

State/Country Buy Value Sell Value
United States 3 - - -
  Ohio 1 - - -
  New Jersey 1 - - -
  Massachusetts 1 - - -
Australia 1 - - -
United Kingdom 1 - - -
Domestic 1 (20%) - - -
Cross-border 4 (80%) - - -
Total 5 - - -

M&A Connections

Deals
Acquired from
Investor(s)
20%
1 (20%)

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.